Risk of perinatal transmission of hepatitis B virus in Jordan

Infectious Disease in Obstetrics and Gynecology

Volumn 10, Issue 3, 2002, Pages 127-132

  Batayneh, Naji ^a   Bdour, Salwa ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Hepatitis B markers; Jordan; Maternal transmission of HBV; Pregnancy

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; JORDAN; PASSIVE IMMUNIZATION; PRENATAL SCREENING; PRIORITY JOURNAL; SOCIAL STATUS; VERTICAL TRANSMISSION; VIRUS CARRIER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHI-SQUARE DISTRIBUTION; DISEASE TRANSMISSION, VERTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT, NEWBORN; JORDAN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL CARE; PREVALENCE; PROBABILITY; RISK ASSESSMENT; SEROLOGIC TESTS;

EID: 0036917472     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1155/S1064744902000121     Document Type: Article

References (15)

1. Pujol FH, Rodriguez I, Martinez N, et al. Viral hepatitis serological markers among pregnant women in Caracas, Venezuela: Implication for perinatal transmission of hepatitis B and C. G E N 1994;48:25-8
2. Duff P. Hepatitis in pregnancy. Semin Perinatol 1998;22:277-83
3. Lazizi Y, Badur S, Perk Y, et al. Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine 1997;15:1095-100
4. Beasly RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983;147:185-90
5. Bahn A, Hilbert K, Martin U, et al. Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants. J Med Virol 1995;47:336-41
6. Beasly RP. Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56
7. Poovorawan Y, Sanpavat S, Pongpunlert W, et al. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HbeAg-positive mothers. J Am Med Assoc 1989;261:3278-81
8. Ngui SL, Andrews NJ, Underhill GS, et al. Failed postnatal immunoprophylaxis for hepatitis B: Characteristics of maternal hepatitis B virus as risk factor. Clin Infect Dis 1998;27:100-6
9. Andre FE, Zuckerman AJ. Review: Protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994;44:144-51
10. Lin HH, Hsu HY, Lee TY, et al. Age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. Asia Oceania J Obstet Gyaecol 1994;20:141-5
11. Balistreri WF. Viral hepatitis. Pediatr Clin North Am 1988;35:375-407
12. Bart PA, Jacquier P, Zuber PLF, et al. 1996. Seroprevalence of HBV (anti-HBc, HbsAg and anti-HBs) and HDV infections among 9006 women at delivery. Liver 1996;16:110-16
13. Kuru U, Turan O, Kuru N, et al. Prevalence of hepatitis B virus in pregnant Turkish women and their families. Eur J Clin Microbiol Infect Dis 1996;15:248-51
14. Guidozzi F, Schoub B, Johnson S, Song E. Should pregnant urban South African women be screened for hepatitis B? S Afr Med J 1993;83:103-5
15. Centers for Disease Control. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40:1-25